Tendons and bones

Tendons and bones constitute the primary structural elements of the musculoskeletal system, comprising specialized osseous and dense connective tissues. Bones provide a rigid framework for the body, protect internal organs, and serve as the central site for mineral storage and hematopoiesis (StatPearls, NBK441968). Tendons are fibrous tissues primarily composed of type I collagen that facilitate movement by transmitting mechanical forces from muscles to the skeletal system (StatPearls, NBK513237). While 'Tendons and bones' is a tissue-level classification rather than a discrete molecular target, it is the focus of significant therapeutic activity, particularly in the management of osteoporosis through drugs like bisphosphonates or RANKL inhibitors (NIH, Osteoporosis Overview). Pathological conditions range from systemic metabolic bone loss to mechanical tendon injuries, necessitating treatments that target specific cellular pathways, such as the RANK/RANKL/OPG axis in bone or tenocyte-mediated repair in tendons. Effective clinical management involves balancing bone remodeling and maintaining the structural integrity of the collagenous tendon matrix.

Other names

Musculoskeletal systemConnective and osseous tissuesSkeletal systemDense regular connective tissue

Pharmacological interaction with these tissues involves diverse mechanisms such as the inhibition of osteoclast-mediated bone resorption (e.g., via bisphosphonates or RANKL inhibitors), stimulation of osteoblast-mediated bone formation (e.g., PTH analogs), or the modulation of inflammatory and healing responses in tendinous collagen matrices.